Have we found the “definitive cancer biomarker”?. The diagnostic and therapeutic implications of human chorionic gonadotropin‐beta expression as a key to malignancy

Cancer

Volumn 76, Issue 8, 1995, Pages 1299-1301

  Regelson, William ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; TUMOR MARKER;

CANCER INVASION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EDITORIAL; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL;

ANIMAL; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 0029127743     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19951015)76:8<1299::AID-CNCR2820760802>3.0.CO;2-L     Document Type: Editorial

References (33)

1. Human chorionic gonadotropinsubunit gene expression in cultured human fetal and cancer cells of different types and origins
2. Flow cytometry method for the analysis of membrane‐associated human chorionic gonadotropin, its subunits and fragments on human cancer cells
3. Expression of membrane associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells
4. Expression of hCG, its subunits and fragments by human cultured cancer cells of the nervous system [abstract]
5. In vivo expression of membrane‐associated human chorionic gonadotropin by cells isolated from cancerous human tissues [abstract]
6. Immunological detection of membrane‐associated human luteinizing hormone correlates with gene expression in cultured human cancer and fetal cells
7. Biosynthesis of human chorionic gonadotropin
8. Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurement
9. Choriocarcinoma: a model for tumor markers
10. Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma
11. Is beta‐human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker for aggressive disease and resistance to radiotherapy
12. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance
13. Growth factors, proto‐oncogenes and human placental development
14. Implantation and the placenta: key pieces of the development puzzle
15. The trophoblastic therapy of cancer (John Beard, 1857‐1924)
16. Increased sialic acid density in surface glycoprotein of transformed and malignant cells: a general phenomenon
17. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines
18. Importance of cell surface carbohydrates in cancer cell adhesion, invasion and metastases
19. Specific inhibition of human natural killer cell‐mediated cytotoxicity by sialic acid and sialo‐oligosaccharides
20. Expression of human choriogonadotropin‐like material correlates with metastatic phenotype of R3230 AC rat adenocarcinoma
21. Human chorionic gonadotropin stimulates proliferation of Nb2 rat lymphoma cells
22. A placental glycoprotein: human chorionic gonadotropin as a growth stimulant of murine tumor cells
23. Human cytotrophoblast invasion is upregulated by epidermal growth factor: evidence that paracrine factors modify this process
24. Involvement of epidermal growth factor (EGF)/EGF receptor autocrine and paracrine mechanism in human trophoblast cells: functional differentiation in vitro
25. A vaccine that prevents pregnancy in women
26. A booster for contraceptive vaccines
27. Clinical and immunological effects of a synthetic beta‐human chorionic gonadotropin vaccine
28. Synthetic hormone/growth factor subunit vaccine with application to antifertility and cancer
29. Effects of immunization against human choriogonadotropin on the growth of transplanted Lewis lung carcinoma and spontaneous mammary adenocarcinoma in mice
30. Antitumor effect of anti‐epidermal growth factor receptor monoclonal antibodies plus cis‐diammine dichloroplatinum on well established A431 cell xenografts
31. Receptor blockade with monoclonal antibodies as anti‐cancer therapy